Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles

N Pavlović, S Goločorbin-Kon, M Ðanić… - Frontiers in …, 2018 - frontiersin.org
Bile acids have received considerable interest in the drug delivery research due to their
peculiar physicochemical properties and biocompatibility. The main advantage of bile acids …

Microbiome-mediated bile acid modification: role in intestinal drug absorption and metabolism

EF Enright, BT Griffin, CGM Gahan, SA Joyce - Pharmacological Research, 2018 - Elsevier
Once regarded obscure and underappreciated, the gut microbiota (the microbial
communities colonizing the gastrointestinal tract) is gaining recognition as an influencer of …

Phenolic compounds inhibit 3T3-L1 adipogenesis depending on the stage of differentiation and their binding affinity to PPARγ

P Aranaz, D Navarro-Herrera, M Zabala, I Miguéliz… - Molecules, 2019 - mdpi.com
Phenolic compounds might modulate adiposity. Here, we report our observation that
polyphenols and phenolic acids inhibit adipogenesis in 3T3-L1 with different intensity …

Semisynthetic bile acids: a new therapeutic option for metabolic syndrome

S Lazarević, M Đanić, S Goločorbin-Kon… - Pharmacological …, 2019 - Elsevier
Bile acids are endogenous emulsifiers synthesized from cholesterol having a peculiar
amphiphilic structure. Appreciation of their beneficial effects on human health, recognized …

Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions

M Đanić, N Pavlović, S Lazarević… - Frontiers in …, 2023 - frontiersin.org
Introduction: Although pharmacogenetics and pharmacogenomics have been at the forefront
of research aimed at finding novel personalized therapies, the focus of research has recently …

PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bile acids

M Đanić, N Pavlović, B Stanimirov, S Lazarević… - European Journal of …, 2021 - Elsevier
Gut microbiota and bile acids possess the ability to modify absorption and pharmacokinetic
profile of numerous drugs. Since the variability of gliclazide response in patients cannot be …

Potential applications of gliclazide in treating type 1 diabetes mellitus: formulation with bile acids and probiotics

M Mikov, M Đanić, N Pavlović, B Stanimirov… - European Journal of …, 2018 - Springer
A major advancement in therapy of type 1 diabetes mellitus (T1DM) is the discovery of new
treatment which avoids and even replaces the absolute requirement for injected insulin. The …

Bile acids as novel enhancers of CNS targeting antitumor drugs: A comprehensive review

M Gvoic, S Vukmirovic, H Al-Salami… - Pharmaceutical …, 2021 - Taylor & Francis
Despite a relatively low prevalence of primary brain tumors, they continuously attract
scientific interest because of the complexity of their treatment due to their location behind the …

Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites

M Đanić, N Pavlović, D Zaklan, B Stanimirov… - Frontiers in …, 2024 - frontiersin.org
Background Gliclazide, a second-generation sulfonylurea derivative still widely used as a
second-line treatment for type 2 diabetes mellitus, is well known to be subject to …

Intestinal microbiota, probiotics and their interactions with drugs: knowledge, attitudes and practices of health science students in Serbia

M Đanić, N Marković, T Ostojić, M Kojić… - BMC Medical …, 2024 - Springer
Background Acquiring sufficient knowledge and understanding the importance of intestinal
microbiota and probiotics in health and disease, as well as their potential for interactions …